Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000436276 | SCV000513987 | pathogenic | not provided | 2022-12-14 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 25525159, 23190751, 15942875, 22924495, 17565729, 29304373, 34013836, 32677741) |
Baylor Genetics | RCV001336054 | SCV001529339 | pathogenic | Acute myeloid leukemia | 2018-03-20 | criteria provided, single submitter | clinical testing | This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported in patients with Sotos syndrome [PMID 15942875] |
Labcorp Genetics |
RCV000436276 | SCV001590380 | pathogenic | not provided | 2023-07-14 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 378304). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Sotos syndrome (PMID: 15942875, 17565729, 23190751). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg788*) in the NSD1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NSD1 are known to be pathogenic (PMID: 12464997, 14571271, 15942875, 16247291). |
Genome- |
RCV003231474 | SCV002054916 | pathogenic | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003231474 | SCV002805676 | pathogenic | Sotos syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing |